Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -714.20x is 45% above its 5-year average of -1301.23x, near the high end of its 5-year range (-3450.00x–-252.10x).
As of the fiscal period ended Friday, September 30, 2022. 48.86% above its 12-month average of -1396.53x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2022 (2022-09-30): -714.20x.
INTEREST COVERAGE RATIO
-714.20x
INTEREST COVERAGE RATIO AVG TTM
-1396.53x
INTEREST COVERAGE RATIO AVG 3Y
-1224.59x
INTEREST COVERAGE RATIO AVG 5Y
-1301.23x
INTEREST COVERAGE RATIO AVG 10Y
-1100.33x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+48.86%
CURRENT VS 3Y AVG
+41.68%
CURRENT VS 5Y AVG
+45.11%
CURRENT VS 10Y AVG
+35.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-12791.70%
vs the sector median at left
Phio Pharmaceuticals Corp.
Market Cap
$11.44M
Interest Coverage Ratio
-714.20x
TTM Avg
-1396.53x
3Y Avg
-1224.59x
5Y Avg
-1301.23x
Market Cap
$11.54M
Interest Coverage Ratio
26.76x
TTM Avg
26.76x
3Y Avg
26.76x
5Y Avg
26.76x
Market Cap
$11.52M
Interest Coverage Ratio
-20.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Interest Coverage Ratio
-473.91x
TTM Avg
210.31x
3Y Avg
210.31x
5Y Avg
210.31x
Market Cap
$11.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.62M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.44M | -714.20x | -1396.53x | -1224.59x | -1301.23x |
| Pluri Inc. (PLUR)vs › | $11.54M | 26.76x | 26.76x | 26.76x | 26.76x |
| Biofrontera Inc. (BFRI)vs › | $11.52M | -20.24x | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -473.91x | 210.31x | 210.31x | 210.31x |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.69M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.08M | -1265.39x | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.36M | -4.24x | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.62M | -1171.55x | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | -57.26x | N/A | N/A | N/A |
Interest Coverage
-714.2x
Debt/Equity
0.00
Current Ratio
15.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-09-30 | -714.20x |
| 2022-06-30 | -252.10x |
| 2022-03-31 | -1320.00x |
| 2021-12-31 | -3450.00x |
| 2021-09-30 | -1246.33x |
| 2021-06-30 | -894.67x |
| 2021-03-31 | -1819.00x |
| 2020-09-30 | -768.67x |
| 2020-06-30 | -556.33x |
| 2017-12-31 | -1991.00x |
| 2014-03-31 | -381.67x |
| 2013-12-31 | -104.92x |
| 2013-09-30 | -207.10x |
| 2013-06-30 | -491.25x |
| 2012-12-31 | -1712.00x |
| 2012-09-30 | -1696.00x |
| 2012-06-30 | -1277.17x |
| 2012-03-31 | -86.59x |
| 2011-12-31 | -2490.00x |
| 2011-03-31 | -5275.00x |
